Category: colorectal cancer
Universal Screening for Lynch Syndrome: Can Tumor Sequencing Have a Larger Public Health Impact on Treatment and Prevention of Colorectal Cancer?
![Universal Screening with an arrow labeled Lynch Syndrome and DNA below it](https://blogs.cdc.gov/genomics/wp-content/uploads/sites/20/2018/05/2018-05_blog_lynch.jpg)
Lynch syndrome (LS) is the most common hereditary syndrome associated with increased risk of colorectal cancer (CRC), accounting for about 3% of CRC patients. LS is a dominantly inherited condition with mutations in several mismatch repair (MMR) genes. Persons with LS are also at increased risk for endometrial and other cancers. Lynch syndrome affects 1 Read More >
Posted on byMaking Universal Screening for Lynch Syndrome a Reality: The Lynch Syndrome Screening Network
![flow chart individual](https://blogs.cdc.gov/genomics/wp-content/uploads/sites/20/2012/03/FlowChartIndividual.jpg)
Every day, about 400 people in the United States are diagnosed with colorectal cancer. Approximately twelve of them have Lynch syndrome, a hereditary condition that increases the risk of colorectal cancer and other cancers. Identifying people with Lynch syndrome could have substantial health benefits for them, their families, and communities. Read More >
Posted on by 1 Comment